VRTX
Vertex Pharmaceuticals Incorporated (VRTX)
Last Price$488.3(2.3%)
Market Cap$124.8B
$11.0B
+11.5% YoY
($535.6M)
N/A
($4,366.4M)
Net Debt to FCF - 5.5x
($790.3M)
(7.2% margin)

VRTX Income Statement

VRTX Income Statement Overview

Annual
Quarterly
LTM
Dec'15
Dec'16
Dec'17
Dec'18
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
Dec'24
$11.0B 11.7% YoY
$9,489.6M 10.3% YoY
86.1% margin
Cost of revenue
$1,530.5M 21.3% YoY
Operating expenses
$9,722.5M 103.6% YoY
Net income
$535.6M 0.0% YoY
(4.9%) margin
Other: $4,092.3M
R&D
$3,630.3M 14.8% YoY
32.9% of revenue
SG&A
$1,464.3M 28.8% YoY
13.3% of revenue

VRTX Income statement key metrics

Annual
Quarterly
LTM

Revenue

$11.0B +11.7% YoY

Operating Income

($0.2B) N/A

Net Income

($0.5B) N/A

VRTX Balance Sheet

VRTX Balance Sheet Overview

Annual
Quarterly
LTM
Dec'15
Dec'16
Dec'17
Dec'18
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
Dec'24
Assets
Liabilities
Total assets
$22.5B
Current assets ($9,596.4M, 42.6% of total)
$6,115.9M (27.1%)
$1,609.4M (7.1%)
Other current assets
$1,871.1M (8.3%)
Non-current assets ($12.9B, 57.4% of total)
$5,107.9M (22.7%)
$825.9M (3.7%)
Other non-current assets
$4,418.4M (19.6%)
Financial position
($4,366.4M)
$6,115.9M$1,749.5M
Cash & Short-term Investments
Total Debt

VRTX Balance Sheet Metrics

Annual
Quarterly
LTM

Assets

$22.5B -0.9% YoY

Liabilities

$6,123.6M +18.9% YoY

Shareholder's Equity

$16.4B -6.7% YoY

VRTX Cash Flow Statement

VRTX Cash Flow Statement Overview

Annual
Quarterly
LTM
Dec'15
Dec'16
Dec'17
Dec'18
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
Dec'24
Cash Beginning of PeriodOperating Cash FlowInvesting Cash FlowFinancing Cash FlowForex Changes on CashCash End of Period$10.4B($492.6M)($3,770.0M)($1,494.9M)($42.6M)$4,572.2M

VRTX Cash Flow Statement key metrics

Annual
Quarterly
LTM

Operating Cash Flow (OCF)

($492.6M) N/A YoY

Capital Expenditure (CAPEX)

($297.7M) +15.2% YoY

Free Cash Flow (FCF)

($790.3M) N/A YoY

VRTX Financials

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Dec'05Dec'06Dec'07Dec'08Dec'09Dec'10Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24
% growth
160.9
56.6%
216.4
34.5%
199.0
(8.0%)
175.5
(11.8%)
102.0
(41.9%)
143.4
40.5%
1,410.6
883.9%
1,527.0
8.3%
1,212.0
(20.6%)
580.4
(52.1%)
1,032.3
77.9%
1,702.2
64.9%
2,488.7
46.2%
3,047.6
22.5%
4,162.8
36.6%
6,205.7
49.1%
7,574.4
22.1%
8,930.7
17.9%
9,869.2
10.5%
11,020.1
11.7%
Cost of Goods Sold (COGS)10.112.213.915.714.212.780.5279.9130.361.0125.5210.5275.1409.5547.8736.3904.21,080.31,262.21,530.5
% margin
150.8
93.7%
204.2
94.4%
185.1
93.0%
159.8
91.1%
87.8
86.1%
130.6
91.1%
1,330.1
94.3%
1,247.2
81.7%
1,081.7
89.3%
519.4
89.5%
906.8
87.8%
1,491.7
87.6%
2,213.5
88.9%
2,638.1
86.6%
3,615.1
86.8%
5,469.4
88.1%
6,670.2
88.1%
7,850.4
87.9%
8,607.0
87.2%
9,489.6
86.1%
Operating Expenses292.5429.6597.8618.2680.0825.21,108.41,243.01,281.11,160.91,373.31,480.51,820.71,974.12,413.02,600.03,891.23,485.04,775.09,722.5
Research & Development Expenses (R&D)248.5371.7513.1516.3550.7637.4707.7806.2918.8855.5996.21,047.71,324.61,416.51,754.51,829.53,051.12,540.33,162.93,630.3
Selling, General & Administrative Expenses (SG&A)44.057.984.7101.9129.3187.8400.7436.8362.3305.4377.1432.8496.1557.6658.5770.5840.1944.71,136.61,464.3
(149.9)
(93.2%)
(229.0)
(105.9%)
(419.8)
(210.9%)
(462.7)
(263.6%)
(613.4)
(601.1%)
(696.1)
(485.5%)
113.8
8.1%
2.3
0.2%
(903.4)
(74.5%)
(692.4)
(119.3%)
(468.7)
(45.4%)
9.9
0.6%
123.2
5.0%
635.2
20.8%
1,197.6
28.8%
2,856.3
46.0%
2,782.1
36.7%
4,307.4
48.2%
4,307.5
43.6%
(232.9)
(2.1%)
Interest Income0.00.00.016.35.02.01.91.90.00.00.00.011.70.063.722.24.9144.6614.7598.1
Interest Expense0.00.00.013.513.219.336.614.722.772.984.281.457.634.158.558.261.554.844.130.6
Pre-tax Income(173.4)(206.9)(426.9)(464.2)(642.2)(754.6)60.4(12.4)(976.1)(734.9)(559.6)(67.4)(15.7)600.21,394.93,116.82,730.44,232.44,379.8248.5
% effective tax rate
61.7
(35.6%)
(18.5)
8.9%
(21.4)
5.0%
(30.7)
6.6%
19.3
(3.0%)
19.3
(2.6%)
19.3
31.9%
38.8
(313.0%)
(288.6)
29.6%
7.0
(0.9%)
30.4
(5.4%)
16.7
(24.7%)
(107.3)
684.1%
(1,486.9)
(247.7%)
218.1
15.6%
405.2
13.0%
388.3
14.2%
910.4
21.5%
760.2
17.4%
784.1
315.5%
% margin
(203.4)
(126.4%)
(206.9)
(95.6%)
(391.3)
(196.6%)
(459.9)
(262.0%)
(641.6)
(628.7%)
(754.6)
(526.3%)
29.6
2.1%
(107.0)
(7.0%)
(445.0)
(36.7%)
(738.6)
(127.2%)
(558.1)
(54.1%)
(112.1)
(6.6%)
263.5
10.6%
2,096.9
68.8%
1,176.8
28.3%
2,711.7
43.7%
2,342.1
30.9%
3,322.0
37.2%
3,619.6
36.7%
(535.6)
(4.9%)
EPS(2.28)(1.83)(3.03)(3.27)(3.70)(3.77)0.14(0.50)(1.98)(3.14)(2.32)(0.46)1.068.254.5810.449.0912.9714.05(2.08)
Diluted EPS(2.28)(1.83)(3.03)(3.27)(3.70)(3.77)0.14(0.50)(1.98)(3.14)(2.31)(0.46)1.048.094.5110.299.0112.8213.89(2.08)
% margin
(114.4)
(71.1%)
(199.5)
(92.2%)
(385.2)
(193.6%)
(426.2)
(242.8%)
(598.9)
(586.9%)
(704.9)
(491.7%)
133.9
9.5%
42.5
2.8%
(554.8)
(45.8%)
(598.8)
(103.2%)
(411.3)
(39.8%)
75.5
4.4%
103.3
4.1%
706.8
23.2%
1,560.4
37.5%
3,284.5
52.9%
2,917.5
38.5%
4,435.5
49.7%
4,605.2
46.7%
486.3
4.4%